临床外科杂志 ›› 2025, Vol. 33 ›› Issue (9): 969-973.doi: 10.3969/j.issn.1005-6483.20240905

• 论著 • 上一篇    下一篇

食管癌病人血清lncRNA CASC11、lncRNA THOR表达水平及其临床意义

侯英利 冯晓娜 李春晖 侯永超 殷星   

  1. 056000 河北省邯郸市第一医院肿瘤一科
  • 收稿日期:2024-06-11 出版日期:2025-10-16 发布日期:2025-10-16
  • 通讯作者: 殷星,Email:x53qjr@163.com

Expression levels and clinical significance of serum lncRNA CASC11 and lncRNA THOR in patients with esophageal cancer

HOU Yingli,FENG Xiaona,LI Chunhui,HOU Yongchao,YIN Xing   

  1. Department of Oncology 1,the First Hospital of Handan City,Handan 056000,China
  • Received:2024-06-11 Online:2025-09-20 Published:2025-10-16

摘要: 目的 探讨食管癌病人血清长链非编码核糖核酸癌症易感候选基因11(lncRNA CASC11)、睾丸相关高度保守的致癌长链非编码核糖核酸(lncRNA THOR)表达水平及其临床意义。方法 2017年1月~2021年1月收治的食管癌病人129例作为观察组,本院同期体检者129例作为对照组。采用RT-qPCR法检测血清lncRNA CASC11、lncRNA THOR表达水平;采用Kaplan-Meier法分析3年生存率;采用ROC曲线分析诊断价值。结果 观察组和对照组血清lncRNA CASC11分别为1.48±0.35 和1.01±0.20、lncRNA THOR分别为1.54±0.28 和1.11±0.15,两组比较差异有统计学意义(P<0.05);浸润深度为T3~T4、肿瘤长度>4cm、TNM分期为Ⅲ~Ⅳ、淋巴结转移病人血清lncRNA CASC11、lncRNA THOR高表达比例高于浸润深度T1~T2、肿瘤长度≤4cm、TNM分期为Ⅰ~Ⅱ、淋巴结未发生转移病人,差异有统计学意义(P<0.05)。随访3年后,129例食管癌病人死亡52例,生存77例。lncRNA CASC11高表达和低表达病人3年生存率分别为32.20% 和82.86%,lncRNA THOR高表达和低表达病人3年生存率分别为36.07% 和 80.88%,差异有统计学意义(P<0.05);血清lncRNA CASC11、lncRNA THOR水平诊断食管癌的曲线下面积(AUC)分别为0.888、0.914,截断值分别为1.29、1.32,二者联合诊断的AUC为0.946,二者联合诊断优于各自单独诊断(Z二者联合-lncRNA CASC11=2.410、Z二者联合-lncRNA THOR=2.167,P=0.010、0.040)。结论 食管癌病人血清lncRNA CASC11、lncRNA THOR水平上调,与病人的3年生存率有关,二者联合对食管癌的诊断具有更高效能。

关键词: 食管癌;生存率;长链非编码核糖核酸癌症易感候选基因11;睾丸相关高度保守的致癌长链非编码核糖核酸

Abstract: Objective To investigate the expression levels and clinical significance of serum long chain non coding RNA cancer susceptibility candidate 11(lncRNA CASC11) and Testis-associated highly-conserved oncogenic long non-coding RNA(lncRNA THOR) in esophageal cancer patients.Methods Esophageal cancer patients diagnosed in our hospital from January 2017 to January 2021 were selected as the observation group(n=129),and healthy individuals who underwent physical examination in our hospital(n=129) were as the control group.Serum lncRNA CASC11 and lncRNA THOR expression levels were detected by RT-qPCR;the 3-year survival rate was analyzed by Kaplan-Meier method;and the diagnostic value was analyzed by ROC curve.Results The expression levels of serum lncRNA CASC11(1.48±0.35 vs 1.01±0.20) and lncRNA THOR(1.54±0.28 vs 1.11±0.15) in the observation group were obviously higher than those in the control group(P<0.05).The proportions of high expression of serum lncRNA CASC11 and lncRNA THOR in patients with infiltration depth of T3~T4,tumor diameter>4cm,TNM staging of Ⅲ-Ⅳ,and lymph node metastasis were obviously higher than those in patients with infiltration depth T1~T2,tumor diameter ≤ 4cm,TNM staging Ⅰ-Ⅱ,and no lymph node metastasis(P<0.05).After 3-year of follow-up,52 out of 129 esophageal cancer patients died and 77 survived.The 3-year survival rate of patients with high expression of lncRNA CASC11(32.20% vs 82.86%) and lncRNA THOR(36.07% vs 80.88%) was obviously lower than that of patients with low expression of lncRNA CASC11 and lncRNA THOR(P<0.05).The area under the curve(AUC) of serum lncRNA CASC11 and lncRNA THOR levels for diagnosing esophageal cancer was 0.888 and 0.914,respectively,with cutoff value of 1.29 and 1.32.The AUC of the combined diagnosis of the two was 0.946,and the combined diagnosis of the two was superior to their individual diagnosis(Zcombination-lncRNA CASC11=2.410,Zcombination-lncRNA THOR=2.167,P=0.010,0.040).Conclusion The serum levels of lncRNA CASC11 and lncRNA THOR in patients with esophageal cancer are upregulated,they are obviously associated with the 3-year survival rate of patients,and the combination of the two has higher efficacy in the diagnosis of esophageal cancer.

Key words: esophageal cancer;survival rate;long chain non coding RNA cancer susceptibility candidate 11;testis-associated highly-conserved oncogenic long non-coding RNA

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 宫念樵. 器官捐献供肾质量评估[J]. 临床外科杂志, 2016, 24(10): 729 .
[2] 胡善彪;余少杰;彭龙开. 婴幼儿供肾移植[J]. 临床外科杂志, 2016, 24(10): 741 .
[3] 石宇;刘学刚 . 冠状动脉旁路移植术后短期内应用强化他汀对患者出血风险的研究[J]. 临床外科杂志, 2016, 24(10): 750 .
[4] 齐卫鹏;王剑明;刘颜;等. 术前应用靛氰绿检测联合三维重建成像评估肝门部胆管癌肝脏储备功能[J]. 临床外科杂志, 2016, 24(10): 756 .
[5] 李光焰;张安平;王祥峰;等. 直肠癌切除术后吻合口狭窄14例分析[J]. 临床外科杂志, 2016, 24(10): 772 .
[6] 张忠伟;刘扬;路明. 痔上黏膜环切术治疗直肠前突所致出口梗阻型便秘的疗效观察[J]. 临床外科杂志, 2016, 24(10): 774 .
[7] 戴强;徐康;周治军;等. 湖北天门地区泌尿系结石成分及特征分析[J]. 临床外科杂志, 2016, 24(10): 789 .
[8] 刘琼;江辉. 喉罩在小儿舌系带矫正手术中的应用[J]. 临床外科杂志, 2016, 24(10): 792 .
[9] 周观金;彭昊;陈森. 全膝关节置换治疗膝关节炎术后早期镇痛的研究进展[J]. 临床外科杂志, 2016, 24(10): 804 .
[10] 万松林;刘韦成;吴云华;等. 胃间质瘤腹腔内破裂出血一例[J]. 临床外科杂志, 2016, 24(10): 807 .